Studies have examined its activity in musculoskeletal tissue models including tendon, ligament, and bone repair research, as well as gastrointestinal cytoprotection and neurological models
This formulation is a dual peptide blend combining TB-500 and BPC-157, designed for laboratory research involving peptide signaling pathways and cellular interaction models
Contrary to expectations 86 , CV event rate (including stroke) in SELECT was in line with that described in GLP-1RA CVOT conducted in patients with diabetes 84,85
The primary antibodies used included anti-phospho-Smad2, anti-phospho-Smad3, anti-Smad2/3 complex, and anti-GAPDH (all purchased from Cell Signaling Technology, Danvers, MA, U.S.A.)
BPC 157-treated defects were also smaller in both depth and size